Medtronic Recalls Stent System After Trial Patient Death
The U.S. Food and Drug Administration on Tuesday said that Medtronic is voluntarily issuing a global recall of a model of unused thoracic stent graft systems following the death of a...To view the full article, register now.
Already a subscriber? Click here to view full article